Trigger point therapy for Cluster Headache involves targeted injection of local anesthetics or botulinum toxin into myofascial trigger points, which aims to disrupt aberrant neuromuscular signaling and reduce pain transmission. By inactivating specific muscle trigger points, particularly in the head, neck, and shoulder regions, the therapy modulates nociceptive pathways and potentially interrupts the neurogenic inflammatory cascade associated with cluster headache pathogenesis.